Clinical Trials Directory

Trials / Conditions / Chronic Central Serous Chorioretinopathy

Chronic Central Serous Chorioretinopathy

11 registered clinical trials studyying Chronic Central Serous Chorioretinopathy — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingSteroid Eye Drops in Chronic Central Serous Chorioretinopathy
NCT05633576
Radboud University Medical CenterPhase 3
CompletedTreatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasm
NCT04224831
Ankara Universitesi TeknokentN/A
UnknownPhotodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy
NCT03079141
Leiden University Medical CenterPhase 4
UnknownPseudo-PDT in Central Serous Chorioretinopathy
NCT02799992
Università degli Studi di BresciaN/A
CompletedEplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
NCT02462499
Semmelweis UniversityPhase 4
CompletedProspective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
NCT01797861
Radboud University Medical CenterPhase 4
CompletedRanibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopat
NCT01325181
Jang Won HeoPhase 1 / Phase 2
CompletedMicroperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
NCT01434095
Surugadai Nihon University HospitalN/A
CompletedTreatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
NCT00489840
Manhattan Eye, Ear & Throat HospitalPhase 1 / Phase 2
CompletedA Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole
NCT00211393
Manhattan Eye, Ear & Throat HospitalPhase 2
CompletedPhotodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)
NCT00211445
Manhattan Eye, Ear & Throat HospitalPhase 2